The majority of Directors of Investor Relations at Albany Molecular Research believe they're not compensated fairly. 100% of Directors of Investor Relations at Albany Molecular Research say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Albany Molecular Research